Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders

Journal Article · · Anaerobe

Evidence supporting that gut problems are linked to ASD symptoms has been accumulating both in humans and animal models of ASD. Gut microbes and their metabolites may be linked not only to GI problems but also to ASD behavior symptoms. Despite this high interest, most previous studies have looked mainly at microbial structure, and studies on fecal metabolites are rare in the context of ASD. Thus, we aimed to detect fecal metabolites that may be present at significantly different concentrations between 21 children with ASD and 23 neurotypical children and to investigate its possible link to human gut microbiome. Using NMR spectroscopy and 16S rRNA gene amplicon sequencing, we examined metabolite profiles and microbial compositions in fecal samples, respectively. Of the 59 metabolites detected, isopropanol concentrations were significantly higher in feces of children with ASD after multiple testing corrections. We also observed similar trends of fecal metabolites to previous studies; children with ASD have higher fecal p-cresol and possibly lower GABA concentrations. In addition, Fisher Discriminant Analysis (FDA) with leave-out-validation suggested that a group of metabolites- caprate, nicotinate, glutamine, thymine, and aspartate- may potentially function as a biomarker to separate ASD participants from the neurotypical group (78% sensitivity and 81% specificity). Consistent with our previous Arizona cohort study, we also confirmed lower gut microbial diversity and reduced relative abundances of Prevotella copri in children with ASD. After multiple testing corrections, we also learned that relative abundances of Feacalibacterium prausnitzii and Haemophilus parainfluenzae were lower in feces of children with ASD. Despite a relatively short list of fecal metabolites, the data in this study support that children with ASD have altered metabolite profiles in feces when compared with neurotypical children and warrant further investigation of metabolites in larger cohorts.

Research Organization:
Pacific Northwest National Laboratory (PNNL), Richland, WA (United States). Environmental Molecular Sciences Laboratory (EMSL)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC05-76RL01830
OSTI ID:
1422278
Report Number(s):
PNNL-SA-127135; 49112; 48610; WN0219080
Journal Information:
Anaerobe, Vol. 49, Issue C; ISSN 1075-9964
Publisher:
Elsevier
Country of Publication:
United States
Language:
English

References (77)

Autism March 2014
The Central Nervous System and the Gut Microbiome November 2016
Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring September 2017
Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report January 2010
Gastrointestinal Symptoms in Autism Spectrum Disorder: A Meta-analysis April 2014
Impaired Carbohydrate Digestion and Transport and Mucosal Dysbiosis in the Intestines of Children with Autism and Gastrointestinal Disturbances September 2011
Gastrointestinal microbiota in children with autism in Slovakia January 2015
Pyrosequencing study of fecal microflora of autistic and control children August 2010
Real-Time PCR Quantitation of Clostridia in Feces of Autistic Children November 2004
Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children October 2005
Gastrointestinal Microflora Studies in Late‐Onset Autism September 2002
Fecal Microbiota and Metabolome of Children with Autism and Pervasive Developmental Disorder Not Otherwise Specified October 2013
Low Relative Abundances of the Mucolytic Bacterium Akkermansia muciniphila and Bifidobacterium spp. in Feces of Children with Autism July 2011
Application of Novel PCR-Based Methods for Detection, Quantitation, and Phylogenetic Characterization of Sutterella Species in Intestinal Biopsy Samples from Children with Autism and Gastrointestinal Disturbances January 2012
Comparison of Fecal Microbiota in Children with Autism Spectrum Disorders and Neurotypical Siblings in the Simons Simplex Collection October 2015
Molecular Characterisation of Gastrointestinal Microbiota of Children With Autism (With and Without Gastrointestinal Dysfunction) and Their Neurotypical Siblings: GI microbiota of children with autism September 2012
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders December 2013
Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: Relevance to autism spectrum disorder February 2011
Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring June 2016
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve August 2011
Pre- and Neonatal Exposure to Lipopolysaccharide or the Enteric Metabolite, Propionic Acid, Alters Development and Behavior in Adolescent Rats in a Sexually Dimorphic Manner January 2014
Oxytocin, Vasopressin, and the Neurogenetics of Sociality November 2008
Can oxytocin treat autism? February 2015
Effect of a vitamin/mineral supplement on children and adults with autism December 2011
Increased serum levels of glutamate in adult patients with autism December 2006
Metabolic Perturbance in Autism Spectrum Disorders: A Metabolomics Study October 2012
Urinary Metabolic Phenotyping Differentiates Children with Autism from Their Unaffected Siblings and Age-Matched Controls June 2010
Urinary p -cresol is elevated in young French children with autism spectrum disorder: a replication study May 2014
Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism November 2016
Elevated Fecal Short Chain Fatty Acid and Ammonia Concentrations in Children with Autism Spectrum Disorder April 2012
Evaluation of the bacterial diversity among and within individual venous leg ulcers using bacterial tag-encoded FLX and Titanium amplicon pyrosequencing and metagenomic approaches January 2009
QIIME allows analysis of high-throughput community sequencing data April 2010
Search and clustering orders of magnitude faster than BLAST August 2010
Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons January 2011
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis January 2009
Conservation evaluation and phylogenetic diversity January 1992
UniFrac: a New Phylogenetic Method for Comparing Microbial Communities December 2005
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences August 2013
KEGG: new perspectives on genomes, pathways, diseases and drugs November 2016
Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks November 2003
Isopropanol poisoning May 2014
Can Alcohol-Based Hand-Rub Solutions Cause You To Lose Your Driver's License? Comparative Cutaneous Absorption of Various Alcohols March 2007
Toxic Alcohol Ingestions: Clinical Features, Diagnosis, and Management November 2007
Treatment of the alcohol intoxications: ethylene glycol, methanol and isopropanol January 2000
Studies on the Organism Producing Isopropanol from Acetone. Part IV [アセトンを還元してイソプロパノールを生成する細菌に就て(第6報)] January 1960
Alcohol dehydrogenase: multiplicity and relatedness in the solvent-producing clostridia October 1995
Acetone, Isopropanol, and Butanol Production by Clostridium beijerinckii (syn. Clostridium butylicum) and Clostridium aurantibutyricum January 1983
Acetone-butanol-isopropanol production byClostridium beijerinckii (synonym,Clostridium butylicum) May 1986
Urinary p-cresol in autism spectrum disorder March 2013
p -Hydroxyphenylacetate decarboxylase from Clostridium difficile : A novel glycyl radical enzyme catalysing the formation of March 2001
Resistant starch reduces colonic and urinary p -cresol in rats fed a tyrosine-supplemented diet, whereas konjac mannan does not October 2016
The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair February 2004
Effects of intestinal bacteria-derived p-cresyl sulfate on Th1-type immune response in vivo and in vitro January 2014
Distinct Urinary Metabolic Profile of Human Colorectal Cancer December 2011
The deleterious metabolic and genotoxic effects of the bacterial metabolite p-cresol on colonic epithelial cells August 2015
The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders July 2012
Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP-Activated Protein Kinase in Caco-2 Cell Monolayers July 2009
Potential beneficial effects of butyrate in intestinal and extraintestinal diseases January 2011
Epigenetic Factors and Autism Spectrum Disorders March 2013
GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders November 2014
Role of octanoic and decanoic acids in the control of seizures. December 1986
Seizure control by decanoic acid through direct AMPA receptor inhibition November 2015
NMDA receptors and ligands in the vertebrate CNS January 1988
NMDA receptor dysfunction in autism spectrum disorders February 2015
Roles of glutamine in neurotransmission November 2010
Serotonin: a mediator of the brain-gut connection October 2000
Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study January 2017
Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia April 2017
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients October 2008
Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii , a commensal bacterium deficient in Crohn’s disease June 2015
Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome November 2011
Abnormal intestinal permeability in children with autism September 1996
Alterations of the Intestinal Barrier in Patients With Autism Spectrum Disorders and in Their First-degree Relatives January 2010
Haemophilus parainfluenzae as a marker of the upper respiratory tract microbiota changes under the influence of preoperative prophylaxis with or without postoperative treatment in patients with lung cancer April 2016
Immune Response to Haemophilus parainfluenzae in Patients with Chronic Obstructive Lung Disease January 2000
Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life May 2015
Gastrointestinal Microbiome Signatures of Pediatric Patients With Irritable Bowel Syndrome November 2011

Cited By (19)

Annual Research Review: Critical windows – the microbiota–gut–brain axis in neurocognitive development November 2019
Rett Syndrome and Other Neurodevelopmental Disorders Share Common Changes in Gut Microbial Community: A Descriptive Review August 2019
The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders September 2018
The Microbiota-Gut-Brain Axis October 2019
The Role of Gut Microbiota in Gastrointestinal Symptoms of Children with ASD July 2019
The contribution of microbiology to neuroscience: More complex than it seems? January 2019
Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders March 2019
Altered composition and function of intestinal microbiota in autism spectrum disorders: a systematic review January 2019
Impaired Spatial Cognition in Adult Rats Treated with Multiple Intracerebroventricular (ICV) Infusions of the Enteric Bacterial Metabolite, Propionic Acid, and Return to Baseline After 1 Week of No Treatment: Contribution to a Rodent Model of ASD March 2019
Untargeted Metabolomics for Autism Spectrum Disorders: Current Status and Future Directions September 2019
Systematic Analysis of Impact of Sampling Regions and Storage Methods on Fecal Gut Microbiome and Metabolome Profiles January 2020
The phenolic interactome and gut microbiota: opportunities and challenges in developing applications for schizophrenia and autism May 2019
Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota April 2019
Microbiota transplant therapy and autism: lessons for the clinic November 2019
Microbiome programming of brain development: implications for neurodevelopmental disorders March 2019
Probiotic supplementation in trained trotter horses: effect on blood clinical pathology data and urine metabolomic assessed in field August 2018
An approach to gut microbiota profile in children with autism spectrum disorder November 2019
Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report December 2008
Defining and Evaluating Microbial Contributions to Metabolite Variation in Microbiome-Metabolome Association Studies December 2019